FDA to unveil measures to accelerate vape, nicotine pouch approvals

Summary

The US Food and Drug Administration (FDA) is set to announce measures aimed at expediting the approval process for vaping products and nicotine pouches, according to a report by the Wall Street Journal. This move may involve revisiting a 2021 rule governing new tobacco applications and simplifying the requirements for scientific studies to facilitate a faster review process. Tobacco companies have previously urged President Donald Trump for a clearer and more efficient FDA authorization system, reflecting the Trump administration's ongoing effort to promote lower-risk alternatives to traditional smoking while ensuring strict regulations to prevent youth access. Recently, the FDA has granted marketing orders for new nicotine products, aligning with this policy direction.

Analysis

Donald Trump: Donald Trump is the President of the United States whose administration oversees the FDA and has prioritized expanding access to regulated nicotine alternatives for adult smokers. His team has expressed commitment to curbing youth access and counterfeits while supporting clearer authorization processes. The news highlights industry lobbying of the Trump administration for faster FDA reviews of vapes and pouches. Carlos Méndez: Carlos Méndez is a Reuters journalist based in Mexico City who contributes to international news coverage, including regulatory and policy developments. He co-reported the story on the FDA's expected measures to accelerate vaping and nicotine pouch approvals. Angela Christy M: Angela Christy M is a Reuters correspondent who covers business, markets, and global news developments. She co-reported the article detailing the Wall Street Journal's report on upcoming FDA steps for faster tobacco product authorizations. US Food and Drug Administration: The US Food and Drug Administration is the federal agency responsible for regulating tobacco products, including vapes and nicotine pouches, through premarket review pathways like the PMTA. It evaluates products for public health impact, balancing adult smoker benefits against youth risks. In this news, the agency is set to announce procedural changes to speed up approvals and revisit prior rules on tobacco applications. Policy: The Trump administration has focused on authorizing nicotine products that may serve as lower-risk alternatives for adults seeking to quit smoking while maintaining strict controls on youth access. Regulation: The FDA has pursued efficiencies in reviewing nicotine pouch applications through a dedicated pilot program that applies streamlined processes to other tobacco products. Authorizations: Recent FDA actions have included granting marketing orders for additional nicotine pouch products from major manufacturers following scientific reviews.

Categories

politicsmacro

Related sources

View Original Tweet